Health Care up on Rotation into Laggards

Dow Jones05:51

Health-care companies rose as traders rotated into sectors that have lagged this year.

Moderna shares rallied after it revealed development of potential autoimmune treatments. The program is part of Moderna's efforts to diversify following a struggle with its vaccine program in the wake of Covid-19 successes.

Eli Lilly shares soared to all-time highs after European regulators issued a recommendation for its Jaypirca product as a treatment for a strain of leukemia.

European Union officials opened an antitrust probe into Sanofi to assess whether the French drugmaker's marketing campaign for a flu vaccine breached competition rules.

Separately, the European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

June 26, 2026 17:51 ET (21:51 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646039367?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-27 05:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646039367","market":"us","top_or_hot":-1,"title":"Health Care up on Rotation into Laggards","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose as traders rotated into sectors that have lagged this year. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> shares rallied after it revealed development of potential autoimmune treatments. The program is part of Moderna's efforts to diversify following a struggle with its vaccine program in the wake of Covid-19 successes. \n</p>\n<p>\n  Eli Lilly shares soared to all-time highs after European regulators issued a recommendation for its Jaypirca product as a treatment for a strain of leukemia. \n</p>\n<p>\n  European Union officials opened an antitrust probe into <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> to assess whether the French drugmaker's marketing campaign for a flu vaccine breached competition rules. \n</p>\n<p>\n  Separately, the European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2026 17:51 ET (21:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Care up on Rotation into Laggards</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Care up on Rotation into Laggards\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-27 05:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose as traders rotated into sectors that have lagged this year. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> shares rallied after it revealed development of potential autoimmune treatments. The program is part of Moderna's efforts to diversify following a struggle with its vaccine program in the wake of Covid-19 successes. \n</p>\n<p>\n  Eli Lilly shares soared to all-time highs after European regulators issued a recommendation for its Jaypirca product as a treatment for a strain of leukemia. \n</p>\n<p>\n  European Union officials opened an antitrust probe into <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> to assess whether the French drugmaker's marketing campaign for a flu vaccine breached competition rules. \n</p>\n<p>\n  Separately, the European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2026 17:51 ET (21:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2646039367","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2646039367","pubTimestamp":1782510660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Health-care companies rose as traders rotated into sectors that have lagged this year.Moderna shares rallied after it revealed development of potential autoimmune treatments. The program is part of Moderna's efforts to diversify following a struggle with its vaccine program in the wake of Covid-19 successes.Eli Lilly shares soared to all-time highs after European regulators issued a recommendation for its Jaypirca product as a treatment for a strain of leukemia.European Union officials opened an antitrust probe into Sanofi to assess whether the French drugmaker's marketing campaign for a flu vaccine breached competition rules.Separately, the European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked.Write to Rob Curran at rob.curran@dowjones.com Dow Jones NewswiresJune 26, 2026 17:51 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","XBI":"SPDR S&P Biotech ETF","BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股"},"translate_title":"医疗保健轮流成为落后者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"LABU":0.6,"XBI":0.6},"content_text":"Health-care companies rose as traders rotated into sectors that have lagged this year. \n\n\nModerna shares rallied after it revealed development of potential autoimmune treatments. The program is part of Moderna's efforts to diversify following a struggle with its vaccine program in the wake of Covid-19 successes. \n\n\n  Eli Lilly shares soared to all-time highs after European regulators issued a recommendation for its Jaypirca product as a treatment for a strain of leukemia. \n\n\n  European Union officials opened an antitrust probe into Sanofi to assess whether the French drugmaker's marketing campaign for a flu vaccine breached competition rules. \n\n\n  Separately, the European Medicines Agency has called for Tavneos, a medication owned by Amgen and licensed in Europe by CSL's Vifor, to have its marketing authorization revoked. \n\n\n \n\n\n  Write to Rob Curran at rob.curran@dowjones.com \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2026 17:51 ET (21:51 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646039367","isCrawlerRequest":true}